Key result
In Taiwan, the predominant PCV2 genotype shifted from PCV2b to PCV2d after 2010, with an estimated nucleotide substitution rate of 8.467 × 10^-4 substitutions per site per year.
Why the study?
Porcine circovirus type 2 causes significant economic losses in the swine industry, and the prevalence and phylodynamics of its genotypes in Taiwan needed investigation.
Observational (n=214)
Effect estimate: 8.467 × 10^-4 substitutions per site per year (95% CI 5.973 × 10^-4 to 1.132 × 10^-3)
Porcine circovirus type 2 (PCV2) is an important pathogen that causes significant economic losses in the swine industry worldwide. Five major PCV2 genotypes have been identified, including PCV2a, PCV2b, PCV2c, PCV2d, and PCV2e. To investigate the prevalence and phylodynamics of the different PCV2 genotypes in Taiwan, 214 PCV2 ORF2 sequences from Taiwan and other countries were analyzed. Genotypic differences were observed among PCV2a, 2b, and 2d at amino acid position 89 in ORF2, with isoleucine (I), arginine (R), and leucine (L), respectively. Similar to other countries, a genotypic shift was also observed in Taiwan, where the predominant genotype shifted from PCV2b to 2d after 2010. The estimated nucleotide substitution rate of Taiwanese strains in the ORF2 region was 8.467 × 10 −4 substitutions per site per year. This rapid evolution rate of PCV2 may lead to the genotypic shift observed in Taiwan. The times to the most recent common ancestor (TMRCA) for PCV2a, -2b, and -2d-2 was dated to 1970, 1992 and 2004, respectively. Thus, the PCV2a, -2b, and -2d genotypes were already present in Taiwan before the introduction of the PCV2 vaccine.
No takes yet. Share an insight, caveat, or question.
Tsai et al. (2019) conducted an observational in Porcine circovirus type 2 (PCV2) infection (n=214). Time period (2001-2017) was evaluated on Nucleotide substitution rate of Taiwanese strains in the ORF2 region (8.467 × 10^-4 substitutions per site per year, 95% CI 5.973 × 10^-4 to 1.132 × 10^-3). In Taiwan, the predominant PCV2 genotype shifted from PCV2b to PCV2d after 2010, with an estimated nucleotide substitution rate of 8.467 × 10^-4 substitutions per site per year.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: